MétaCan
Menu
Back to cohort
Record W4299361804 · doi:10.4244/eij-d-22-00319

Ticagrelor with and without aspirin in patients with a prior coronary artery bypass graft undergoing percutaneous coronary intervention: the TWILIGHT-CABG study

2022· article· en· W4299361804 on OpenAlexafffund
Gennaro Sardella, Frans Beerkens, George Dangas, Davide Cao, Usman Baber, Samantha Sartori, David J. Cohen, Carlo Briguori, Robert Gil, Johny Nicolas, Zhongjie Zhang, Dariusz Dudek, Vijay Kunadian, Ran Kornowski, Giora Weisz, Bimmer E. Claessen, Steven O. Marx, Javier Escaned, Kurt Huber, Timothy Collier, David J. Moliterno, E. Magnus Ohman, Mitchell W. Krucoff, Adnan Kastrati, Dominick J. Angiolillo, Shamir Mehta, Richard Shlofmitz, Samin K. Sharma, Stuart Pocock, C. Michael Gibson, Roxana Mehran

Bibliographic record

VenueEuroIntervention · 2022
Typearticle
Languageen
FieldMedicine
TopicAntiplatelet Therapy and Cardiovascular Diseases
Canadian institutionsHamilton Health Sciences
FundersJanssen PharmaceuticalsFaculty of Medical Sciences, Newcastle UniversityAbbott VascularSt. Jude MedicalNational Institutes of HealthCytoSorbents EuropeHumanitas Research HospitalMicroPortIdorsia PharmaceuticalsInstitut National de la Santé et de la Recherche MédicaleNewcastle UniversityFakultet Medicinskih Nauka, Univerziteta U KragujevcuUniversidad Complutense de MadridSanofiAbiomedLondon School of Hygiene and Tropical MedicineOsprey MedicalNewcastle upon Tyne Hospitals NHS Foundation TrustCanada Excellence Research Chairs, Government of CanadaMedicines CompanyDuke Clinical Research InstituteEisaiCytokineticsAstraZenecaAmarin CorporationRevanceBoston Scientific CorporationHamilton Health SciencesBristol-Myers SquibbEli Lilly and CompanyAbbott LaboratoriesCSL BehringMyoKardiaDaiichi Sankyo EuropeServierGilead SciencesUniversity of Oklahoma Health Sciences CenterCovis PharmaDeutsches Zentrum für Herz-KreislaufforschungUniversity of OklahomaPfizerBioClinicaAmgen
KeywordsMedicineTicagrelorPercutaneous coronary interventionAspirinInternal medicineHazard ratioConventional PCICardiologyStroke (engine)Myocardial infarctionClinical endpointRandomized controlled trialConfidence interval

Abstract

fetched live from OpenAlex

BACKGROUND: Prior coronary artery bypass graft surgery (CABG) patients undergoing percutaneous coronary intervention (PCI) are often older and present with multiple comorbidities. Ticagrelor monotherapy after a short course of dual antiplatelet therapy (DAPT) has emerged as an effective bleeding-avoidance strategy among high-risk patients. AIMS: We aimed to examine the effects of ticagrelor with or without aspirin in prior CABG patients undergoing PCI within the TWILIGHT trial. METHODS: After 3 months of ticagrelor plus aspirin, patients were randomised to either aspirin or placebo, in addition to ticagrelor, for 12 months and compared by prior CABG status. The primary endpoint was Bleeding Academic Research Consortium (BARC) type 2, 3 or 5 bleeding. The key secondary endpoint was all-cause death, myocardial infarction (MI), or stroke. RESULTS: =0.484). When comparing target vessel type, treatment effects were consistent among graft- and native-vessel interventions. CONCLUSIONS: In high-risk patients with prior CABG, ticagrelor monotherapy reduced bleeding without compromising ischaemic outcomes compared with ticagrelor plus aspirin.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.010
Threshold uncertainty score0.645

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.009
GPT teacher head0.230
Teacher spread0.221 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations6
Published2022
Admission routes2
Has abstractyes

Explore more

Same venueEuroInterventionSame topicAntiplatelet Therapy and Cardiovascular DiseasesFrench-language works237,207